Transgender Health And The Impact Of Aging And Menopause

April 2023 in “ Climacteric ”

Ada S. Cheung, Brendan J. Nolan, Sav Zwickl

gender affirming hormone therapy GAHT feminizing hormone therapy masculinizing therapy sex steroid levels venous thromboembolism myocardial infarction stroke osteoporosis polycythemia pelvic pain cardiovascular risk management bone health optimization

Studysummary This review discusses the long-term effects of gender affirming hormone therapy and reports no new clinical findings, recommending a shared decision-making approach to balance benefits and risks for transgender individuals.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Research Gaps in Medical Treatment of Transgender and Nonbinary People

19 citations , February 2021 in “Journal of Clinical Investigation”

This review discusses the challenges and research gaps in transgender health care, highlighting the need for dedicated research infrastructure and funding to develop a more comprehensive evidence base.

research A Systematic Review of Antiandrogens and Feminization in Transgender Women

31 citations , September 2020 in “Clinical endocrinology”

This review found limited evidence on the effectiveness of different antiandrogens for feminization in transgender women, suggesting cyproterone acetate, leuprolide, and medroxyprogesterone acetate may better suppress testosterone than spironolactone or estradiol alone.

research Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients

57 citations , December 2018 in “JAMA Surgery”

This systematic review suggests that current evidence does not support routinely discontinuing gender-affirming hormone treatments before surgery, especially testosterone and spironolactone, due to limited data on related perioperative risks.

research Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline

2170 citations , September 2017 in “The Journal of Clinical Endocrinology & Metabolism”

This updated guideline from the Endocrine Society highlights the importance of endocrinologists in providing safe and effective hormone regimens for gender-affirming care, especially for adolescents who have entered puberty.